Evmann Creates Roadmap to Facilitate its Development into a €1 Billion Global Company

Dutch Evmann Investments Holding, the parent company of VSY Biotechnology, organized its 2022 Global Leadership Meeting last week in line with its strategic plans to become a "unicorn" company. "Unicorn" is a term used in the venture capital industry to describe a privately held startup company with a value of over $1 billion.

Over the 2-day meeting, Evmann's Board of directors and leaders from the global functions and markets reviewed mid and long-term strategies and aligned on a comprehensive roadmap. This roadmap builds on Evmann's strategic plans to expand its business segments and reveals further details on how the company will achieve its ultimate goal of developing into a Unicorn company with over €1 billion in assets.

"Evmann has been undergoing a full-scale transformation to achieve the company's vision. We will keep focusing on accelerating the transition to future business models. As a result, we will become even more agile in adapting the fast-changing global dynamics while expanding our business operations into other segments," said Dr. Ercan Varlibas, Chairman of Evmann's board.

Fatih Ergin, CEO of the Dutch Group, indicated that Evmann would soon be investing in therapeutic fields and will explore opportunities to extend its businesses in new geographic and business areas.

Evmann Investments Holding BV is a holding company with significant investments in ophthalmology and orthopedics. Its purpose is to make investments that simultaneously create value and improve health, in line with its motto, "Invest for Life."

Evmann's headquarters is in Amsterdam, the Netherlands. Its global businesses are managed through its two leading German group companies, VSY Biotechnology GmbH and Alsanza Medizintechnik und Pharma GmbH, which deliver products to more than 80 countries. The development of innovative products through R&D activities is one of Evmann's strategical priorities, and its main focus is to create sustainable growth in all areas it operates in.